Loading company…
Amsterdam platform connecting patients, physicians and biopharma companies to treatments still in development.
Founded in 2012 and based in Amsterdam, Netherlands, Impatients N.V., doing business as myTomorrows, runs a technology platform that links patients, physicians and BioPharma companies to treatments still in development. Services include clinical trial participation, Expanded Access Programs and real-world data collection. In October 2025 it raised USD 29 million in Series C funding from new investor Avego.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in